Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus [5]

Rheumatology

Volumn 40, Issue 10, 2001, Pages 1195-1196

  Leibovitch, I ^a,b   Goldstein, M ^a   Loewenstein, A ^a   Barak, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CANDESARTAN HEXETIL; ENALAPRIL MALEATE; PHOSPHOLIPID ANTIBODY; PREDNISONE; STEROID;

ADULT; ANAMNESIS; CASE REPORT; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; OPHTHALMOSCOPY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VISUAL IMPAIRMENT;

EID: 0034771343     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.10.1195     Document Type: Letter

References (6)

1. Severe retinal vaso-occlusive disease in systemic lupus erythematosus
2. Retinal casculitis
3. Retinal disease in patients with systemic lupus erythematosus
4. Antiphospholipid antibodies: A risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome
5. The lupus anticoagulant and retinal vaso-occlusive disease
6. Retinopathy in systemic lupus erythematosus